NEW COMPOUNDS

Details for Australian Patent Application No. 2003268064 (hide)

Owner ASTRAZENECA AB

Inventors Slassi, Abdelmalik; Kers, Annika; McLeod, Donald A.; Stormann, Thomas M.; Oscarsson, Karin; Edwards, Louise; Isaac, Methvin; Malmberg, Johan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003268064

PCT Number PCT/US03/24912

PCT Pub. Number WO2004/014370

Priority 60/402,039 09.08.02 US

Filing date 8 August 2003

Wipo publication date 25 February 2004

International Classifications

A61K 031/4245 - Oxadiazoles

C07D 261/14 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 413/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 271/06 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 271/10 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 261/08 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61P 025/00 Drugs for disorders of the nervous system

C07D 271/07 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 271/113 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/402,039 09.08.02 US

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2003268064

6 December 2007 Assignment before Grant

  AstraZeneca AB; NPS Pharmaceuticals, Inc. The application has been assigned to AstraZeneca AB

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003268065-METHOD AND DEVICE FOR ADVANCING LEAD AND ERASER IN MECHANICAL PENCILS AND PEN AND ERASERS IN PENS

2003268063-SYSTEM AND METHOD FOR RECEIVING AND TRANSFERRING A TELEPHONE DIRECTORY FROM ONE CELLULAR TELEPHONE TO THE SAME OR ANOTHER